TR201722493A2 - Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon - Google Patents

Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon Download PDF

Info

Publication number
TR201722493A2
TR201722493A2 TR2017/22493A TR201722493A TR201722493A2 TR 201722493 A2 TR201722493 A2 TR 201722493A2 TR 2017/22493 A TR2017/22493 A TR 2017/22493A TR 201722493 A TR201722493 A TR 201722493A TR 201722493 A2 TR201722493 A2 TR 201722493A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical composition
posaconazol
composition containing
solid pharmaceutical
posaconazole
Prior art date
Application number
TR2017/22493A
Other languages
English (en)
Inventor
Ulusoy Bozyel Müge
Zengi̇ner Si̇bel
Türkyilmaz Ali̇
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/22493A priority Critical patent/TR201722493A2/tr
Priority to EP18918419.5A priority patent/EP3731827A2/en
Priority to PCT/TR2018/050906 priority patent/WO2019240698A2/en
Publication of TR201722493A2 publication Critical patent/TR201722493A2/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, posakonazol serbest bazını veya posakonazolün farmasötik olarak kabul edilebilir tuzlarını, kristalin polimorflarını, solvatlarını, hidratlarını veya esterlerini ve bir dispersiyon taşıyıcı içeren bir farmasötik kompozisyonla ilgilidir. Üstelik, kompozisyon, etkili bir proses kullanılarak elde edilmektedir.
TR2017/22493A 2017-12-28 2017-12-28 Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon TR201722493A2 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2017/22493A TR201722493A2 (tr) 2017-12-28 2017-12-28 Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
EP18918419.5A EP3731827A2 (en) 2017-12-28 2018-12-26 Oral pharmaceutical composition comprising posaconazole
PCT/TR2018/050906 WO2019240698A2 (en) 2017-12-28 2018-12-26 Oral pharmaceutical composition comprising posaconazole

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/22493A TR201722493A2 (tr) 2017-12-28 2017-12-28 Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon

Publications (1)

Publication Number Publication Date
TR201722493A2 true TR201722493A2 (tr) 2019-07-22

Family

ID=67900711

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2017/22493A TR201722493A2 (tr) 2017-12-28 2017-12-28 Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon

Country Status (3)

Country Link
EP (1) EP3731827A2 (tr)
TR (1) TR201722493A2 (tr)
WO (1) WO2019240698A2 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4196096A1 (en) 2020-08-13 2023-06-21 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant high-strength formulation containing posaconazole
EP4091604B1 (en) 2021-11-25 2024-04-03 Alfred E. Tiefenbacher (GmbH & Co. KG) Granules containing posaconazole
WO2023012378A1 (en) 2021-11-25 2023-02-09 Alfred E. Tiefenbacher (Gmbh Und Co. Kg) Granules containing posaconazole

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703079A (en) 1993-12-21 1997-12-30 Schering Corporation Tetrahydrofuran antifungals
US5661151A (en) 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
ID29290A (id) 1997-10-07 2001-08-16 Schering Corp Susunan kristal bentuk-banyak yang dapat membasmi jamur
DE10014588A1 (de) * 2000-03-27 2001-10-04 Basf Ag Wirkstoffhaltige Schwimmformen enthaltend Polyvinylacetat und Polyvinylpyrrolidon, deren Verwendung und Herstellung
SG170047A1 (en) * 2006-05-30 2011-04-29 Elan Pharma Int Ltd Nanoparticulate posaconazole formulations
US20150231081A1 (en) * 2014-02-20 2015-08-20 Cadila Healthcare Limited Delayed release posaconazole tablets
EP3331501B1 (en) * 2015-08-08 2019-09-11 Alfred E. Tiefenbacher (GmbH & Co. KG) Gastro-resistant formulation containing posaconazole
TR201620462A2 (tr) * 2016-12-31 2018-07-23 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CN108066289B (zh) * 2017-12-28 2021-01-26 广州玻思韬控释药业有限公司 一种泊沙康唑固体分散体及其制备方法和泊沙康唑肠溶制剂
CA3098306C (en) * 2018-05-14 2024-04-16 Capsugel Belgium Nv Solid dosage forms with high active agent loading

Also Published As

Publication number Publication date
EP3731827A2 (en) 2020-11-04
WO2019240698A2 (en) 2019-12-19
WO2019240698A3 (en) 2020-02-13

Similar Documents

Publication Publication Date Title
PH12017500408A1 (en) Heteroaryl compunds as btk inhibitors and uses thereof
MX2018002986A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1 (irak) y sus usos.
WO2015200677A8 (en) Prmt5 inhibitors and uses thereof
PH12015501996B1 (en) Heterocyclic compounds and uses thereof
MX2021003792A (es) Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2.
NZ721617A (en) Heterocyclic compounds
NZ739676A (en) Heteroaryl compounds as irak inhibitors and uses thereof
PH12015502248A1 (en) 6-(5-hydroxy-1h-pyrazol-1-yl)nicotinamide derivatives and their use as phd inhibitors
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
MA40171A (fr) Dérivés d'azamophinan et leur utilisation
PH12019501639A1 (en) Jaki selective inhibitors
PH12017501641A1 (en) Acetate salt of buprenorphine and methods for preparing buprenorphine
TR201906325T4 (tr) Tetrazolon sübstitüeli dihidropiridinon MGAT2 inhibitörleri.
TR201722493A2 (tr) Posakonazol i̇çeren kati farmasöti̇k kompozi̇syon
MX2015017156A (es) Inhibidores de bace.
EA029499B9 (ru) Ингибиторы rorc2 и способы их применения
IN2013CH05441A (tr)
CL2017002354A1 (es) Compuestos derivados de heteroarilos bicíclicos fusionados con actividad como inhibidores de phd.
CL2015002712A1 (es) Cristales de laquinimod sódico y proceso para la preparación de ellos
MX2019013979A (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
AU2015292632B2 (en) Aldosterone synthase inhibitors
AU2018316542A1 (en) Indole derivatives as histone demethylase inhibitors
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
JOP20190163B1 (ar) منشط nrf2
TR201000689A1 (tr) Sefprozil içeren katı dozaj formlar.